Ayman Maher Nagib Selected Research

Calcineurin Inhibitors

1/2022

Fludrocortisone Among Adult Renal Transplant Recipients With Persistent Hyperkalemia: Single-Center Experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayman Maher Nagib Research Topics

Disease

2	Hypercholesterolemia 01/2024 - 08/2015
2	Body Weight (Weight, Body) 01/2022 - 08/2015
1	Hyperkalemia 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Diabetes Mellitus 01/2019
1	Hepatitis B 10/2015
1	Proteinuria 08/2015
1	Insulin Resistance 08/2015
1	Delayed Graft Function 03/2014

Drug/Important Bio-Agent (IBA)

1	SubtilisinIBA 01/2024
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024
1	Essential DrugsIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Sulfamethoxazole FDA LinkGeneric 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2022
1	FludrocortisoneIBA 01/2022
1	PotassiumIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	ApelinIBA 08/2015

Therapy/Procedure

2	Therapeutics 01/2024 - 03/2014
1	Glycemic Control 01/2019